FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898046788> ?p ?o ?g. }

• W2898046788 endingPage "e0006852" @default.
• W2898046788 startingPage "e0006852" @default.
• W2898046788 abstract "The recommended strategy for control of schistosomiasis is preventive chemotherapy with praziquantel (PZQ). Pre-school children (PSC) are excluded from population treatment programs. In high endemic areas, these children are also at risk, and require treatment with PZQ. The Government of Kenya initiated the National School-Based Deworming Programme (NSBDP) where PSC in Early Childhood Development Education (ECDE) Centers are only eligible for treatment with albendazole (ABZ) but not with PZQ.400 PSC were enrolled, from 10 randomly selected ECDE Centers in Kwale County, Kenya where children were treated with crushed PZQ tablets mixed with orange juice, at a single dose of 40 mg/kg. Adverse events were assessed 24 hours post-treatment through questionnaires administered to the parents or guardians. Acceptability was determined by observing if the child spat and/ or vomited all or part of the PZQ dose immediately after treatment. Efficacy was assessed by examining urine samples for Schistosoma haematobium eggs in the 5 weeks post-treatment follow-up. Children testing negative for S. haematobium during the follow-up were considered cured. Egg reduction rate (ERR) was calculated as the decrement in the infection intensity (group's geometric mean egg counts per 10 ml of urine) following treatment expressed as a proportion of the pre-treatment infection intensity. Before treatment, 80 out of the 400 children enrolled in the study tested positive for S. haematobium (20.0% (95% confidence interval (CI) 16.4-24.2%). Of these, 41 had infections of heavy intensity (51.3%) while the rest (48.7%) were of light intensity. Five weeks post-treatment, 10 children who had heavy intensity infection were diagnosed with S. haematobium (prevalence: 2.5% (95% CI 1.5-4.9%). Infection intensities decreased significantly from 45.9 (95% CI: 31.0-68.0) eggs/ 10 ml urine to1.4 (95% CI: 1.1-1.7) eggs/ 10 ml urine during pre-and post-treatment respectively. The ERR was 96.9%. There were no severe adverse events during follow up 24 hours post treatment. Treatment tolerability among the 400 children was high as none of the children spat and/ or vomited as observed in this study.The study revealed that crushed PZQ is safe and effective in the treatment of urogenital schistosomiasis in this age group. It is therefore recommended that PZQ should be administered to the PSC in Kwale County." @default.
• W2898046788 created "2018-10-26" @default.
• W2898046788 creator A5018986997 @default.
• W2898046788 creator A5020698932 @default.
• W2898046788 creator A5035141474 @default.
• W2898046788 creator A5067769678 @default.
• W2898046788 creator A5074595789 @default.
• W2898046788 date "2018-10-17" @default.
• W2898046788 modified "2023-09-25" @default.
• W2898046788 title "Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya" @default.
• W2898046788 cites W1643526650 @default.
• W2898046788 cites W1917393774 @default.
• W2898046788 cites W1996354214 @default.
• W2898046788 cites W1998145634 @default.
• W2898046788 cites W2011786949 @default.
• W2898046788 cites W2016150993 @default.
• W2898046788 cites W2020157772 @default.
• W2898046788 cites W2029239193 @default.
• W2898046788 cites W2036521891 @default.
• W2898046788 cites W2047711974 @default.
• W2898046788 cites W2058824406 @default.
• W2898046788 cites W2062921719 @default.
• W2898046788 cites W2089807430 @default.
• W2898046788 cites W2109107542 @default.
• W2898046788 cites W2131747268 @default.
• W2898046788 cites W2132087610 @default.
• W2898046788 cites W2132978855 @default.
• W2898046788 cites W2143753520 @default.
• W2898046788 cites W2144059865 @default.
• W2898046788 cites W2146741195 @default.
• W2898046788 cites W2149424590 @default.
• W2898046788 cites W2150934040 @default.
• W2898046788 cites W2152571142 @default.
• W2898046788 cites W2167658370 @default.
• W2898046788 cites W2169306519 @default.
• W2898046788 cites W2258074324 @default.
• W2898046788 cites W2334703999 @default.
• W2898046788 cites W29025525 @default.
• W2898046788 doi "https://doi.org/10.1371/journal.pntd.0006852" @default.
• W2898046788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6205662" @default.
• W2898046788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30332403" @default.
• W2898046788 hasPublicationYear "2018" @default.
• W2898046788 type Work @default.
• W2898046788 sameAs 2898046788 @default.
• W2898046788 citedByCount "12" @default.
• W2898046788 countsByYear W28980467882019 @default.
• W2898046788 countsByYear W28980467882020 @default.
• W2898046788 countsByYear W28980467882021 @default.
• W2898046788 countsByYear W28980467882022 @default.
• W2898046788 countsByYear W28980467882023 @default.
• W2898046788 crossrefType "journal-article" @default.
• W2898046788 hasAuthorship W2898046788A5018986997 @default.
• W2898046788 hasAuthorship W2898046788A5020698932 @default.
• W2898046788 hasAuthorship W2898046788A5035141474 @default.
• W2898046788 hasAuthorship W2898046788A5067769678 @default.
• W2898046788 hasAuthorship W2898046788A5074595789 @default.
• W2898046788 hasBestOaLocation W28980467881 @default.
• W2898046788 hasConcept C126322002 @default.
• W2898046788 hasConcept C165901193 @default.
• W2898046788 hasConcept C187212893 @default.
• W2898046788 hasConcept C197934379 @default.
• W2898046788 hasConcept C203014093 @default.
• W2898046788 hasConcept C2776225656 @default.
• W2898046788 hasConcept C2776908094 @default.
• W2898046788 hasConcept C2777445151 @default.
• W2898046788 hasConcept C2777461070 @default.
• W2898046788 hasConcept C2779744950 @default.
• W2898046788 hasConcept C2780026642 @default.
• W2898046788 hasConcept C2908647359 @default.
• W2898046788 hasConcept C42972112 @default.
• W2898046788 hasConcept C44249647 @default.
• W2898046788 hasConcept C71924100 @default.
• W2898046788 hasConcept C99454951 @default.
• W2898046788 hasConceptScore W2898046788C126322002 @default.
• W2898046788 hasConceptScore W2898046788C165901193 @default.
• W2898046788 hasConceptScore W2898046788C187212893 @default.
• W2898046788 hasConceptScore W2898046788C197934379 @default.
• W2898046788 hasConceptScore W2898046788C203014093 @default.
• W2898046788 hasConceptScore W2898046788C2776225656 @default.
• W2898046788 hasConceptScore W2898046788C2776908094 @default.
• W2898046788 hasConceptScore W2898046788C2777445151 @default.
• W2898046788 hasConceptScore W2898046788C2777461070 @default.
• W2898046788 hasConceptScore W2898046788C2779744950 @default.
• W2898046788 hasConceptScore W2898046788C2780026642 @default.
• W2898046788 hasConceptScore W2898046788C2908647359 @default.
• W2898046788 hasConceptScore W2898046788C42972112 @default.
• W2898046788 hasConceptScore W2898046788C44249647 @default.
• W2898046788 hasConceptScore W2898046788C71924100 @default.
• W2898046788 hasConceptScore W2898046788C99454951 @default.
• W2898046788 hasIssue "10" @default.
• W2898046788 hasLocation W28980467881 @default.
• W2898046788 hasLocation W28980467882 @default.
• W2898046788 hasLocation W28980467883 @default.
• W2898046788 hasLocation W28980467884 @default.
• W2898046788 hasLocation W28980467885 @default.
• W2898046788 hasOpenAccess W2898046788 @default.
• W2898046788 hasPrimaryLocation W28980467881 @default.
• W2898046788 hasRelatedWork W1926278954 @default.

• next